drugset / Trial / NCT00695318

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

NCT00695318

Phase 2 Terminated 17 enrolled Alimera Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the safety and efficacy of Medidur FA treatment in one eye to the sham-treated fellow eye of subjects with geographic atrophy secondary to AMD.

Timeline

Start
2008-12
Primary completion
2013-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.2 ug Intravitreal
Subject fluocinolone acetonide Small molecule 0.5 ug Intravitreal